Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy

Journal of the National Cancer Institute

Volumn 94, Issue 20, 2002, Pages 1564-1569

  Metcalfe, Kelly A ^a   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANADA; CANCER MODEL; CANCER RISK; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DECISION MAKING; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT INFORMATION; PERCEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WILCOXON SIGNED RANKS TEST;

EID: 0037120948     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.20.1564     Document Type: Article

References (21)

1. Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 1994;70:934-8.
2. Dolan NC, Lee AM, McDermott MM. Age-related differences in breast carcinoma knowledge, beliefs, and perceived risk among women visiting an academic general medicine practice. Cancer 1997;80:413-20.
3. Black WC, Nease RF, Tosteson AN, Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87:720-31.
4. Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A. Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 2001;39:139.
5. Vernon SW, Vogel VG, Halabi S, Bondy ML. Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Res Treat 1993;28:137-44.
6. Polednak AP, Lane DS, Burg MA. Risk perception, family history, and use of breast cancer screening tests. Cancer Detect Prev 1991;15:257-63.
7. Drossaert CC, Boer H, Seydel ER. Perceived risk, anxiety, mammographic examination uptake, and breast self-examination of women with a family history of breast cancer: the role of knowing to be at increased risk. Cancer Detect Prev 1996;20:76-85.
8. Hebert-Croteau N, Goggin P, Kishchuk N. Estimation of breast cancer risk by women aged 40 and over: a population-based study. Can J Public Health 1997;88:392-6.
9. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-85.
10. Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, et al. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 1999;79:868-74.
11. Gail MH, Brinton LA, Byar DP, Torle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879-86.
12. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994;73: 643-51.
13. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997;89:227-38.
14. Euhus DM. Understanding mathematical models for breast cancer risk assessment and counseling. Breast J 2001;7:224-32.
15. Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M, et al. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998;35:731-8.
16. Morris KT, Johnson N, Krasikov N, Allen M, Dorsey P. Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer. Am J Surg 2001;181:431-3.
17. Lloyd S, Watson M, Waites B, Meyer L, Eeles R, Ebbs S, et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996;74:482-7.
18. Meiser B, Butow P, Friedlander M, Schnieden V, Gattas M, Kirk J, et al. Intention to undergo prophylactic bilateral mastectomy in women with an increased risk of developing hereditary breast cancer. J Clin Oncol 2000; 18:2250-7.
19. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998;90:1371-88.
20. Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 2000;356:1876-81.
21. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999;91:1475-9.